Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Giza Venture Capital is an Israeli venture capital firm founded in 1992. It manages five funds with a total capitalization of approximately $600-700 million. The firm focuses on seed and early-stage technology companies, including those in Health Tech, Fintech, AI, and Blockchain, with a portfolio of 97-100+ investments and 32-49 exits. It also sponsors affiliated funds in Poland and Spain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Giza Venture Capital.